When Innovation Doesn’t Translate

The Problem No One Talks AboutMost MedTech startups don’t fail because the science is wrong.
They fail because no one changes behavior.
That was the core takeaway from our conversation with Noël Theodosiou, CEO of Luminous—who is helping life sciences companies confront a growing gap between innovation and real-world adoption.

The Industry Playbook (And Why It Falls Short)The traditional path looks like this:

• Prove clinical efficacy
• Secure regulatory clearance
• Engage key opinion leaders
• Launch

On paper, it works.
In reality, many products stall after launch.
Why?
Because this model assumes clinical success leads to adoption.
It doesn’t.

Built for the Lab. Sold Into Reality.Clinical environments are controlled.
Healthcare delivery is not.
Patients don’t behave like trial participants.
Providers don’t operate like your pitch deck.
Health systems don’t move on your timeline.
And most importantly:
Up to 80% of health outcomes are driven outside of clinical care

The Risk Most Teams Miss: AdoptionCompanies spend significant time de-risking:

• Clinical performance
• Regulatory approval
• Reimbursement

But the biggest risk is often overlooked:
Adoption
This includes:

• Workflow disruption
• Behavior change
• Ease of use
• Real-world integration

If these aren’t addressed early, growth becomes unpredictable.

What We’re Seeing Right NowGLP-1s: Breakthrough Meets RealityStrong clinical outcomes—but real-world usage is driven by:

• Patient behavior
• Long-term adherence challenges
• Cultural factors

AI Is Changing the Entry PointPatients are no longer starting with providers.
They’re starting with:

• Search
• AI tools
• Online communities

“Patient-Centric” Isn’t Operational YetThe industry talks about patient centricity.
But rarely builds with patients during development.

The Shift: Innovation → AdoptionThe next wave of successful companies will:

• Design for real-world behavior
• Build around workflow, not just function
• Engage patients and providers early
• Treat usability as a growth driver

The Reality for Founders & InvestorsIf your product requires:

• New behavior
• New workflows
• New incentives

You don’t just have product risk.
You have a go-to-market risk disguised as innovation.

Final ThoughtThe market does not reward innovation alone.
It rewards adoption.
The companies that understand this will lead.
The ones that don’t will struggle to scale.

Listen to the Full Episode🎧 Episode #331: The Patient Trust Shift